news aggregator

Advances in multiple myeloma, lymphoma and other hematologic malignancies presented at ASH

Researchers from University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine presented significant new research findings in multiple myeloma, lymphoma and...

Daily handful of nuts slashes the risk of disease and death

Medical News Today: Oncology News - December 6, 2016 - 17:00
New study suggests the health benefits of nuts may be more wide-reaching than previously thought, and one may only need 20 grams a day to reap the rewards.

Chemotherapy drug may trigger new egg production in women

Medical News Today: Oncology News - December 6, 2016 - 15:00
Small study finds more young eggs in ovaries of women receiving drugs for treating Hodgkin's lymphoma, compared with differently treated or healthy women.

Chemotherapy drug may trigger new egg production in women

Medical News Today: Lymphoma/Leukemia News - December 6, 2016 - 15:00
Small study finds more young eggs in ovaries of women receiving drugs for treating Hodgkin's lymphoma, compared with differently treated or healthy women.

Psychosocial risk factors are associated with high readmission rates, longer hospital stays

Medical News Today: Oncology News - December 6, 2016 - 14:00
A new study shows that psychosocial risk factors that impact a person's ability to cope with chronic stress are associated with significantly higher readmission rates and longer hospital stays...

Combination immune therapy shows promise against Hodgkin lymphoma

Medical News Today: Lymphoma/Leukemia News - December 6, 2016 - 14:00
The combination of two new drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to...

Nivolumab with chemotherapy improves response, survival in AML study patients

Medical News Today: Lymphoma/Leukemia News - December 6, 2016 - 14:00
The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled response rates and improved overall survival in patients with acute myeloid leukemia (AML), according to...

Is smoking ever safe? Study investigates

Medical News Today: Lung Cancer News - December 5, 2016 - 17:00
The harmful effects of smoking are well known, but a new study investigates the health risks associated with a lower level of tobacco use.

Cancer: Molecular insights into anti-tumor effects of diabetes drug

Medical News Today: Oncology News - December 5, 2016 - 15:00
Study sheds new light at molecular level on how widely prescribed diabetes drug metformin protects epithelial barriers against stress and prevents tumors.

How highs and lows in testosterone levels 'shock' prostate cancer cells to death

Medical News Today: Prostate News - December 5, 2016 - 08:00
A strategy of alternately flooding and starving the body of testosterone is producing good results in patients who have metastatic prostate cancer that is resistant to treatment by chemical or...

Proposed biosimilar drug shows potential as breast cancer treatment

Medical News Today: Breast Cancer News - December 5, 2016 - 08:00
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with...

Phase I trial shows that a drug that inhibits the Notch signalling process is active in a range of advanced cancers

Medical News Today: Oncology News - December 5, 2016 - 08:00
A new anti-cancer drug that inhibits a key cell signalling process involved in many different cancers has shown that it is capable of stopping the progression of cancer and shrinking tumours.

Advanced soft tissue sarcomas respond to a combination of a new and an existing anti-cancer drug

Medical News Today: Oncology News - December 5, 2016 - 08:00
Researchers working to find effective treatments for soft tissue sarcomas have discovered that combining a new anti-cancer drug with an existing one kills cancer cells not only in the laboratory...

Vietnam war veteran develops rare cancer after exposure to Agent Orange

Medical News Today: Oncology News - December 5, 2016 - 08:00
A veteran with a rare type of cancer may have developed the condition after being exposed to Agent Orange during the Vietnam War, reveal doctors writing in the journal BMJ Case Reports.

White wine may raise melanoma risk

Medical News Today: Oncology News - December 3, 2016 - 08:00
New study suggests alcohol intake should be considered a risk factor for melanoma, after finding white wine may be independently linked to the skin cancer.

Parker Institute for Cancer Immunotherapy and Cancer Research Institute launch collaboration on cancer neoantigens

Medical News Today: Lung Cancer News - December 1, 2016 - 14:00
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) announce a major collaboration focused on neoantigens.

Benefits of daily aspirin outweigh risk to stomach

Medical News Today: Oncology News - December 1, 2016 - 14:00
Stomach bleeds caused by aspirin are considerably less serious than the spontaneous bleeds that can occur in people not taking the drug, concludes a study led by Cardiff University.

Parker Institute for Cancer Immunotherapy and Cancer Research Institute launch collaboration on cancer neoantigens

Medical News Today: Oncology News - December 1, 2016 - 14:00
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) announce a major collaboration focused on neoantigens.

Cancer patients take comfort in peer stories on online forums

Medical News Today: Oncology News - December 1, 2016 - 08:00
When faced with potentially life-threatening diseases such as cancer, people often seek information about the disease and support from peers.

Anti-cancer drug, CB-839, in combination with everolimus, stops tumours growing in patients with advanced kidney cancer

Medical News Today: Oncology News - November 30, 2016 - 14:00
The first drug to target a key enzyme that cancer cells need to keep them alive has shown that it is effective in controlling disease in patients with advanced kidney cancer when it is used in...